African Journal of Infectious Diseases Research

ISSN 2756-3340

Table of Contents 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 10, October 2025 | pp. 873–879

DOI: 10.46882/AJIDR/148888

Article Type: Epidemiological Study

Title: Prevalence, risk factors, and clinical manifestations of lymphatic filariasis hydrocele and lymphedema in post-mass drug administration districts

Names of Authors: Baraka Mwangi¹*, Sofie Van Der Berg²

Authors’ Affiliations: ¹Department of Community Health, Sokoine University of Agriculture, Morogoro, Tanzania. ²Department of Global Health, Erasmus University Medical Center, Rotterdam, Netherlands.

Abstract: Chronic filarial morbidity including lymphedema and hydrocele persists in endemic communities even after transmission interruption targets are achieved. We assessed circulating filarial antigenemia and chronic clinical morbidity burden across five districts following seven annual ivermectin and albendazole rounds. Blood samples and physical examinations were conducted for 720 adults aged 18 years and older using filariasis test strips. Circulating filarial antigen prevalence declined to 1.4 percent, yet chronic lymphedema and hydrocele affected 6.8 percent and 9.4 percent of residents, respectively. Scaling up hydrocelectomy surgeries and home-based limb hygiene care remains vital.

Keywords: Lymphatic filariasis, Lymphedema, Hydrocele, Morbidity management, Neglected tropical diseases

Citation: Mwangi B, Van Der Berg S (2025). Prevalence, risk factors, and clinical manifestations of lymphatic filariasis hydrocele and lymphedema in post-mass drug administration districts. African Journal of Infectious Diseases Research, 12(10): 873–879. DOI: 10.46882/AJIDR/148888

Manuscript Timeline: Received: September 04, 2025; Revised: October 04, 2025; Accepted: October 16, 2025; Published: October 24, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 10, October 2025 | pp. 866–872

DOI: 10.46882/AJIDR/148887

Article Type: Research Article

Title: Antimicrobial susceptibility and virulence determinants of Moraxella catarrhalis and Haemophilus influenzae in acute exacerbations of chronic obstructive pulmonary disease

Names of Authors: Youssef Benali¹*, Katrin Hoffmann², Mei-Ling Wong³

Authors’ Affiliations: ¹Department of Pulmonology, Mohammed V University, Rabat, Morocco. ²Department of Respiratory Medicine, Heidelberg University, Heidelberg, Germany. ³Department of Microbiology, University of Hong Kong, Hong Kong, China.

Abstract: Bacterial colonization and acute airway infection drive recurrent exacerbations and lung function decline in chronic obstructive pulmonary disease. We determined the bacterial etiology and beta-lactamase production rates among patients hospitalized with acute exacerbations. Expectorated sputum and bronchoalveolar lavage specimens from 255 patients were cultured alongside multiplex polymerase chain reaction and nitrocefin beta-lactamase testing. Haemophilus influenzae and Moraxella catarrhalis accounted for 32.9 percent and 21.6 percent of bacterial exacerbations, respectively, with beta-lactamase production detected in 94.5 percent of M. catarrhalis isolates. Amoxicillin-clavulanate and doxycycline retained strong clinical efficacy.

Keywords: Haemophilus influenzae, Moraxella catarrhalis, Chronic obstructive pulmonary disease, Beta-lactamase, Respiratory infection

Citation: Benali Y, Hoffmann K, Wong M (2025). Antimicrobial susceptibility and virulence determinants of Moraxella catarrhalis and Haemophilus influenzae in acute exacerbations of chronic obstructive pulmonary disease. African Journal of Infectious Diseases Research, 12(10): 866–872. DOI: 10.46882/AJIDR/148887

Manuscript Timeline: Received: September 01, 2025; Revised: October 01, 2025; Accepted: October 14, 2025; Published: October 21, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 10, October 2025 | pp. 859–865

DOI: 10.46882/AJIDR/148886

Article Type: Original Article

Title: Seroepidemiology and clinical spectrum of Zika virus infection among pregnant women and neonates with microcephaly

Names of Authors: Fatou Diallo¹*, Jonathan Miller², Rafael Mendoza³

Authors’ Affiliations: ¹Department of Obstetrics and Gynecology, Cheikh Anta Diop University, Dakar, Senegal. ²Department of Global Health, University of Washington, Seattle, United States. ³Department of Pediatrics, Cayetano Heredia University, Lima, Peru.

Abstract: Zika virus infection during pregnancy poses substantial risks of congenital neurological malformations and neurodevelopmental impairment. We investigated anti-Zika IgM seroprevalence, acute viremia, and neonatal cranial outcomes among pregnant women presenting with rash and fever. Maternal serum and neonatal cord blood samples from 365 mother-infant pairs were tested via IgM capture enzyme-linked immunosorbent assay, plaque reduction neutralization testing, and reverse transcription polymerase chain reaction. Recent Zika virus infection was confirmed in 8.2 percent of mothers, with congenital microcephaly or intracranial calcifications observed in 13.3 percent of exposed newborns.

Keywords: Zika virus, Congenital Zika syndrome, Microcephaly, Arbovirus surveillance, Pregnancy

Citation: Diallo F, Miller J, Mendoza R (2025). Seroepidemiology and clinical spectrum of Zika virus infection among pregnant women and neonates with microcephaly. African Journal of Infectious Diseases Research, 12(10): 859–865. DOI: 10.46882/AJIDR/148886

Manuscript Timeline: Received: August 29, 2025; Revised: September 29, 2025; Accepted: October 11, 2025; Published: October 18, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 10, October 2025 | pp. 852–858

DOI: 10.46882/AJIDR/148885

Article Type: Research Article

Title: Prevalence, genetic diversity, and zoonotic transmission of Blastocystis subtypes and Dientamoeba fragilis in irritable bowel syndrome patients

Names of Authors: Tendai Chikwanda¹*, Maren Solberg²

Authors’ Affiliations: ¹Department of Medical Microbiology, University of Zimbabwe, Harare, Zimbabwe. ²Department of Parasitology, Norwegian University of Life Sciences, Ås, Norway.

Abstract: Enteric protists such as Blastocystis and Dientamoeba fragilis are frequently detected in patients with chronic functional gastrointestinal symptoms. We determined the prevalence and subtype distribution of Blastocystis and D. fragilis among adults meeting Rome IV criteria for irritable bowel syndrome. Stool samples from 310 patients and 150 healthy controls were analyzed via real-time polymerase chain reaction and small subunit rRNA gene sequencing. Blastocystis was detected in 34.8 percent of patients versus 18.0 percent of controls, with subtype ST3 and ST1 predominating. Targeted antiparasitic therapy alleviated abdominal bloating and diarrhea in symptomatic carriers.

Keywords: Blastocystis, Dientamoeba fragilis, Irritable bowel syndrome, Enteric protists, Subtype distribution

Citation: Chikwanda T, Solberg M (2025). Prevalence, genetic diversity, and zoonotic transmission of Blastocystis subtypes and Dientamoeba fragilis in irritable bowel syndrome patients. African Journal of Infectious Diseases Research, 12(10): 852–858. DOI: 10.46882/AJIDR/148885

Manuscript Timeline: Received: August 26, 2025; Revised: September 27, 2025; Accepted: October 09, 2025; Published: October 15, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 10, October 2025 | pp. 845–851

DOI: 10.46882/AJIDR/148884

Article Type: Clinical Study

Title: Etiology, risk factors, and mortality predictors of central line-associated bloodstream infections in adult oncology patients

Names of Authors: Amira Hassan¹*, Thomas Bennett², Kenji Sato³

Authors’ Affiliations: ¹Department of Clinical Oncology, Cairo University, Cairo, Egypt. ²Department of Infectious Diseases, University of Manchester, Manchester, United Kingdom. ³Department of Hematology, University of Tokyo, Tokyo, Japan.

Abstract: Central line-associated bloodstream infections represent major causes of morbidity, chemotherapy delays, and mortality among immunocompromised cancer patients. We determined incidence rates, causative microorganisms, and antimicrobial resistance profiles of catheter-related bacteremia in an oncology unit. Paired central and peripheral blood cultures from 280 febrile catheterized patients were evaluated using differential time to positivity. Incidence was 9.6 episodes per 1,000 catheter-days, led by coagulase-negative staphylococci, Escherichia coli, and Candida tropicalis. Prolonged neutropenia and femoral catheter placement independently predicted infection and 30-day mortality.

Keywords: Central line-associated bloodstream infection, Oncology patients, Neutropenia, Antimicrobial resistance, Infection control

Citation: Hassan A, Bennett T, Sato K (2025). Etiology, risk factors, and mortality predictors of central line-associated bloodstream infections in adult oncology patients. African Journal of Infectious Diseases Research, 12(10): 845–851. DOI: 10.46882/AJIDR/148884

Manuscript Timeline: Received: August 23, 2025; Revised: September 24, 2025; Accepted: October 06, 2025; Published: October 12, 2025

African Journal of Infectious Diseases Research | Vol. 12, No. 10, October 2025 | pp. 838–844

DOI: 10.46882/AJIDR/148883

Article Type: Research Article

Title: Molecular epidemiology and antifungal susceptibility of Sporothrix schenckii complex isolated from lymphocutaneous sporotrichosis lesions

Names of Authors: Sipho Mokoena¹*, Lukas Weber², Camila Santos³

Authors’ Affiliations: ¹Department of Dermatology, University of the Witwatersrand, Johannesburg, South Africa. ²Institute of Medical Mycology, University of Zurich, Zurich, Switzerland. ³Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

Abstract: Sporotrichosis is a subacute implantation mycosis transmitted via traumatic inoculation from contaminated plant matter or infected felines. We characterized the species identity, clinical presentation, and antifungal susceptibility of Sporothrix isolates recovered from ulcerative nodular lesions. Tissue biopsies and pus aspirates from 115 patients were cultured on Sabouraud dextrose agar and identified via calmodulin gene sequencing alongside broth microdilution testing. Sporothrix schenckii sensu stricto accounted for 84.3 percent of isolates, presenting predominantly as upper-limb lymphocutaneous nodules. Oral itraconazole achieved complete clinical resolution in 92.2 percent of treated patients.

Keywords: Sporotrichosis, Sporothrix schenckii, Subcutaneous mycosis, Itraconazole, Medical mycology

Citation: Mokoena S, Weber L, Santos C (2025). Molecular epidemiology and antifungal susceptibility of Sporothrix schenckii complex isolated from lymphocutaneous sporotrichosis lesions. African Journal of Infectious Diseases Research, 12(10): 838–844. DOI: 10.46882/AJIDR/148883

Manuscript Timeline: Received: August 20, 2025; Revised: September 21, 2025; Accepted: October 03, 2025; Published: October 09, 2025